Verano Holdings (VRNO) Operating Expenses (2021 - 2026)

Verano Holdings' (VRNO) quarterly Operating Expenses came in at $85.9 million in Q1 2026, up 1.53% year-on-year from $84.6 million in Q1 2025, and down 67.38% on a QoQ basis from $263.3 million in Q4 2025.

Verano Holdings (VRNO) Operating Expenses (2021 - 2026) Analysis & Trends

Verano Holdings (VRNO) has 6 years of Operating Expenses data on file, last reported at $85.9 million in Q1 2026.

  • On a quarterly basis, Operating Expenses rose 1.53% year-over-year to $85.9 million in Q1 2026; TTM through Mar 2026 was $521.9 million, a 22.73% decrease from a year earlier, with the FY2025 full-year figure at $520.6 million, down 23.57% from the prior year.
  • Operating Expenses for Q1 2026 stood at $85.9 million, down from $263.3 million in the prior quarter.
  • Over the last five years, Operating Expenses for VRNO reached as high as $411.4 million in Q4 2024 and fell as low as $9.6 million in Q1 2022.
  • Historically, Operating Expenses has averaged $128.4 million across 5 years, with a median of $87.1 million in 2024.
  • On a YoY basis, Operating Expenses climbed as much as 686.07% in 2023 and fell as far as 55.73% in 2023.
  • Year by year, Operating Expenses stood at $310.2 million in 2022, then plunged by 55.73% to $137.3 million in 2023, then jumped by 199.6% to $411.4 million in 2024, then sank by 36.01% to $263.3 million in 2025, then sank by 67.38% to $85.9 million in 2026.
  • Per Business Quant data, the three most recent Operating Expenses figures were $85.9 million in Q1 2026, $263.3 million in Q4 2025, and $86.0 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 1.00 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 788.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 12.58 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 455.70 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 1.24 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 621.10 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 494.00 Mn
10 Verano Holdings 2.02 Bn 1.94 Bn 98.98 Mn 85.88 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 85.88 Mn
Dec 31, 2025 263.28 Mn
Sep 30, 2025 85.96 Mn
Jun 30, 2025 86.77 Mn
Mar 31, 2025 84.58 Mn
Dec 31, 2024 411.42 Mn
Sep 30, 2024 92.33 Mn
Jun 30, 2024 87.07 Mn
Mar 31, 2024 90.29 Mn
Dec 31, 2023 137.32 Mn
Sep 30, 2023 92.89 Mn
Jun 30, 2023 84.66 Mn
Mar 31, 2023 75.24 Mn
Dec 31, 2022 310.22 Mn
Sep 30, 2022 85.71 Mn
Jun 30, 2022 100.26 Mn
Mar 31, 2022 9.57 Mn
Dec 31, 2021 81.77 Mn
Sep 30, 2021 76.48 Mn
Jun 30, 2021 70.01 Mn